P53 EXPRESSION, MUTATION, AND ALLELIC DELETION IN OVARIAN-CANCER

被引:47
作者
MCMANUS, DT
YAP, EPH
MAXWELL, P
RUSSELL, SEH
TONER, PG
MCGEE, JO
机构
[1] QUEENS UNIV BELFAST,DEPT MED GENET,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND
[2] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1002/path.1711740304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this investigation was to study the prevalence of p53 gene mutations and allelic deletions in ovarian cancer and the relationship between these events and p53 expression. Genomic p53 was amplified by the polymerase chain reaction (PCR) from paraffin-embedded sections of tumour and non-tumour tissue. Exons 5-9 were screened for mutations using non-isotopic single-strand conformation polymorphism (SSCP) analysis. Allelic deletions at a sequence polymorphism in exon 4 were studied for loss of heterozygosity (LOH) by restriction analysis and by SSCP. p53 expression was detected by immunohistochemistry with the p53 antibodies CM1 and Do7. Of 44 cases, ten (23 per cent), including a mucinous tumour of low malignant potential, showed mutations. There was a statistically significant correlation between p53 mutation and expression (P<0.01) but seven cases showed discordance. Of 18 informative cases, eight (44 per cent) demonstrated LOH. Mutations were identified in three of the informative cases, two of which also had LOH. The remaining case showed mutations in two amplicons. p53 dysfunction, as indicated by mutation, deletion, or increased expression, is common in ovarian cancer. There is an association between these molecular events but the exact mechanisms of p53 inactivation remain to be elucidated.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 30 条
  • [1] CODON-72 POLYMORPHISM OF THE TP53 GENE
    ARA, S
    LEE, PSY
    HANSEN, MF
    SAYA, H
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (16) : 4961 - 4961
  • [2] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS
    BARNES, DM
    DUBLIN, EA
    FISHER, CJ
    LEVISON, DA
    MILLIS, RR
    [J]. HUMAN PATHOLOGY, 1993, 24 (05) : 469 - 476
  • [3] CONSTANT DENATURANT GEL-ELECTROPHORESIS AS A RAPID SCREENING TECHNIQUE FOR P53 MUTATIONS
    BORRESEN, AL
    HOVIG, E
    SMITHSORENSEN, B
    MALKIN, D
    LYSTAD, S
    ANDERSEN, TI
    NESLAND, JM
    ISSELBACHER, KJ
    FRIEND, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8405 - 8409
  • [4] CALLEMARTIN O, 1990, NUCLEIC ACIDS RES, V18, P4963
  • [5] PREVENTION OF PRE-PCR MIS-PRIMING AND PRIMER DIMERIZATION IMPROVES LOW-COPY-NUMBER AMPLIFICATIONS
    CHOU, Q
    RUSSELL, M
    BIRCH, DE
    RAYMOND, J
    BLOCH, W
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (07) : 1717 - 1723
  • [6] ECCLES DM, 1990, ONCOGENE, V5, P1599
  • [7] OVEREXPRESSION OF THE P53 PROTEIN AND ALLELE LOSS AT 17P13 IN OVARIAN-CARCINOMA
    ECCLES, DM
    BRETT, L
    LESSELS, A
    GRUBER, L
    LANE, D
    STEEL, CM
    LEONARD, RCF
    [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (01) : 40 - 44
  • [8] HALL PA, 1993, ONCOGENE, V8, P203
  • [9] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [10] INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER
    IGGO, R
    GATTER, K
    BARTEK, J
    LANE, D
    HARRIS, AL
    [J]. LANCET, 1990, 335 (8691) : 675 - 679